op 2507 has been researched along with ataprost in 2 studies
| Studies (op 2507) | Trials (op 2507) | Recent Studies (post-2010) (op 2507) | Studies (ataprost) | Trials (ataprost) | Recent Studies (post-2010) (ataprost) |
|---|---|---|---|---|---|
| 33 | 0 | 1 | 66 | 2 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gotoh, M; Kanai, T; Miyoshi, H; Monden, M; Mori, T; Murata, M; Nakano, H; Umeshita, K | 1 |
| Umeki, S | 1 |
2 other study(ies) available for op 2507 and ataprost
| Article | Year |
|---|---|
Cytoprotective effect of prostaglandin I2 analogues on superoxide-induced hepatocyte injury.
Topics: Animals; Calcium; Cells, Cultured; Cyclic AMP; Epoprostenol; L-Lactate Dehydrogenase; Lipid Peroxidation; Liver; Male; Prostaglandins, Synthetic; Rats; Rats, Wistar; Reperfusion Injury; Superoxides | 1994 |
Prostaglandin E and analogs of prostacyclin influencing superoxide production by the human neutrophil NADPH oxidase system.
Topics: Alprostadil; Dose-Response Relationship, Drug; Epoprostenol; Free Radical Scavengers; Humans; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Prostaglandins, Synthetic; Superoxides | 1994 |